U.S. District Court Upholds Final Judgment for XIFAXAN 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029 Pharmaceutical Investing
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia Pharmaceutical Investing
Jamieson Wellness Inc. Closes Previously Announced Partnership with DCP Capital Pharmaceutical Investing
Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation Pharmaceutical Investing
BriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc. Pharmaceutical Investing
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights Pharmaceutical Investing
Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative Pharmaceutical Investing
